Amgen and Simcere partner to develop and commercialise biosimilars in China

US-based biotechnology company Amgen has entered an exclusive agreement with Chinese firm Simcere Pharmaceutical Group to co-develop and commercialise four biosimilars in China.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news